Počet záznamů: 1  

ELIMED, future hadrontherapy applications of laser-accelerated beams

  1. 1.
    0436906 - FZU-D 2015 RIV NL eng J - Článek v odborném periodiku
    Cirrone, Giuseppe A.P. - Carpinelli, M. - Cuttone, G. - Gammino, S. - Jia, S.B. - Korn, Georg - Maggiore, Mario - Manti, L. - Margarone, Daniele - Prokůpek, Jan - Renis, M. - Romano, F. - Schillaci, Francesco - Tomasello, B. - Torrisi, L. - Tramontana, A. - Velyhan, Andriy
    ELIMED, future hadrontherapy applications of laser-accelerated beams.
    Nuclear Instruments & Methods in Physics Research Section A. Roč. 730, Dec (2013), s. 174-177. ISSN 0168-9002.
    [International Conference on Radiation Effects on Semiconductor Materials, Detectors and Devices /9./(RESMDD). Florence, 09.10.2012-12.10.2012]
    Grant CEP: GA ČR(CZ) GAP205/11/1165; GA MŠk ED1.1.00/02.0061; GA MŠk EE.2.3.20.0087
    Grant ostatní:ELI Beamlines(XE) CZ.1.05/1.1.00/02.0061; OP VK 2 LaserGen(XE) CZ.1.07/2.3.00/20.0087
    Institucionální podpora: RVO:68378271
    Klíčová slova: laser acceleration * cancer treatment * particle selection * Monte Carlo simulation * beam handling
    Kód oboru RIV: BH - Optika, masery a lasery
    Impakt faktor: 1.316, rok: 2013

    Laser-ion acceleration has recently gained a great interest as an alternative to conventional and more expensive acceleration techniques. These ion beams have desirable qualities such as small source size, high luminosity and small emittance to be used in different fields as Nuclear Physics, Medical Physics, etc. This is very promising specially for the future perspective of a new concept of hadrontherapy based on laser-based devices could be developed, replacing traditional accelerating machines. Before delivering laser-driven beams for treatments they have to be handled, cleaned from unwanted particles and characterized in order to have the clinical requirements. In fact ion energy spectra have exponential trend, almost 100% energy spread and a wide angular divergence which is the biggest issue in the beam transport and, hence, in a wider use of this technology. In order to demonstrate the clinical applicability of laser-driven beams new collaboration between ELI-Beamlines project researchers from Prague (Cz) and a INEN-LNS group from Catania (I) has been already launched and scientists from different countries have already express their will in joining the project. This cooperation has been named ELIMED (MEDical application at ELIBeamlines) and will take place inside the ELI-Beamlines infrastructure located in Prague. This work describes the schedule of the ELIMED project and the design of the energy selector which will be realized at INEN-LNS.
    Trvalý link: http://hdl.handle.net/11104/0240530